Last deal

Amount

Grant

Stage

28.09.2020

Date

1

all rounds

date founded

Financing round

General

About Company
The Drugs for Neglected Diseases initiative (DNDi) develops affordable treatments for neglected patients worldwide.

Related to

COMPANY NAME TEST4

SHORT DESCRIPTION 4

Location

Dnipro, Dnipropetrovsk Oblast, Ukraine, 49000

total rounds

3

total raised

$2.21M

Industry

Sector :

Subsector :

founded date

01.01.2003

Number of employees

Company Type

Non-profit

Last funding type

Grant

IPO status

Private

Description

DNDi, founded in 2003 by Médecins Sans Frontières (MSF), the World Health Organization, and five international research institutions, collaborates with the research community, public sector, pharmaceutical industry, and other partners to bridge the gaps in essential drugs for neglected diseases. They have developed 9 affordable treatments for 6 deadly diseases since their inception, saving millions of lives.
Contacts

Contact Email

Phone number

Social url

Similar Companies
1000
VR Foundation

VR Foundation

The Vitiligo Research Foundation is a non-profit organization curing Vitiligo.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

New York, NY, USA
EveryLife Foundation for Rare Diseases

EveryLife Foundation for Rare Diseases

The EveryLife Foundation for Rare Diseases accelerates biotech innovation for rare disease treatments.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Keywords

Health Care, Biotechnology, Non-Profit

Location

Novato, CA, USA
Amyloidosis Research Consortium

Amyloidosis Research Consortium

Amyloidosis Research Consortium is a nonprofit organization dedicated to advancing the awareness, science and treatment of amyloid diseases.

Sector

Pharmaceuticals and Biotechnology

Subsector

Biotechnology

Location

Newton, MA, USA
Sabin Vaccine Institute

Sabin Vaccine Institute

The company develops vaccines to prevent diseases and improve global healthcare.

Sector

Pharmaceuticals and Biotechnology

Subsector

Pharmaceuticals

Keywords

Health Care, Biotechnology, Medical

Location

Washington Cir NW, Washington, DC, USA

total rounds

3

total raised

$63.1M

Financials

Funding Rounds
1
1

Number of Funding Rounds

Their latest funding was raised on 28.09.2020. Their latest investor la Caixa. Their latest round Grant

Date 
Funding Round 
Investors 
Money Raised 
Lead 
28.09.2020
1
la Caixa

la Caixa

La Caixa is a Spanish private equity company that invests in infrastructures, energy, and communications sectors, among others.

Sector

Banks

Subsector

Banks

Keywords

Non-Profit, Financial Services, Venture Capital

Location

Barcelona, Spain

count Of Investments

11

count Of Exists

5
Co-Investors
Investors
1
1

Number of lead investors

1

Number of investors

Investor 
Lead 
Round 
Partners 
Yes
Grant
la Caixa

la Caixa

La Caixa is a Spanish private equity company that invests in infrastructures, energy, and communications sectors, among others.

Sector

Banks

Subsector

Banks

Keywords

Non-Profit, Financial Services, Venture Capital

Location

Barcelona, Spain

count Of Investments

11

count Of Exists

5

People

Employee Profiles
14

Anderson Leal

Senior manager global human resources and organization

Olivier Anselmo

Head of human resources and administration

Jaxira Rodriguez

Grant administrator

Ilan Moss

Senior communications manager

Oliver ̜¤Ì£¼Ì›

Communications manager

Jennifer Duran

Development manager

Activity

Recent News
0